Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has acquired FIBERLite Centrifuge, Inc., of Santa Clara, California. FIBERLite is the worldÂ™s foremost supplier of carbon fiber centrifuge rotors, a strong and lightweight alternative that provides customers with a number of advantages over traditional metal rotors, including performance, safety, productivity and durability.
We have been offering FIBERLite rotors as an alternative to aluminum and titanium rotors in our Thermo Scientific laboratory centrifuges for several years, and we have seen customer demand for the technology continue to grow, said Marijn E. Dekkers, president and chief executive officer of Thermo Fisher Scientific. FIBERLiteÂ™s patented carbon fiber rotors, along with its strong patent portfolio, will enhance our centrifugation offering and bring additional R&D capabilities.
Thermo Fisher Scientific designs, develops and manufactures a comprehensive range of high-quality centrifuges, rotors and accessories under the Thermo Scientific brand. Centrifuge models range from bench-top microcentrifuges to floor-standing ultracentrifuges, allowing Thermo Fisher Scientific to support all laboratory applications, from routine sample preparation to cutting-edge cell and molecular biology research techniques.
FIBERLite, which had revenues of approximately $7 million in 2007, will be integrated into Thermo FisherÂ™s Laboratory Products and Services Segment.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer. With annual revenues of $10 billion, we have more than 30,000 employees and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, we help solve analytical challenges from routine testing to complex research and discovery. Thermo Scientific offers customers a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, we offer the most convenient purchasing options to customers and continuously advance our technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike. Visit www.thermofisher.com.
The following constitutes a “Safe Harbor” statement under the Private Securities Litigation Reform Act of 1995: This press release contains forward-looking statements that involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are set forth in the company’s Quarterly Report on Form 10-Q for the quarter ended March 29, 2008, under the caption “Risk Factors,” which is on file with the Securities and Exchange Commission (SEC) and available in the “Investors” section of our Website under the heading “SEC Filings.” Important factors that could cause actual results to differ materially from those indicated by forward-looking statements include risks and uncertainties relating to: the risk that the legacy businesses of Thermo Electron Corporation (“Thermo”) and Fisher Scientific International Inc. (“Fisher”) will not be integrated successfully; the risk that the cost savings and any other synergies from the merger of Thermo and Fisher may not be fully realized or may take longer to realize than expected; competition and its effect on pricing, spending, third-party relationships and revenues; the need to develop new products and adapt to significant technological change; implementation of strategies for improving internal growth; use and protection of intellectual property; dependence on customers’ capital spending policies and government funding policies; realization of potential future savings from new productivity initiatives; general worldwide economic conditions and related uncertainties; the effect of changes in governmental regulations; the effect of exchange rate fluctuations on international operations; the effect of laws and regulations governing government contracts; the effect of competing with certain of our customers and suppliers; and the effect of rapid changes in the healthcare industry. While we may elect to update forward-looking statements at some point in the future, we specifically disclaim any obligation to do so, even if our estimates change and, therefore, you should not rely on these forward-looking statements as representing our views as of any date subsequent to today.
Thermo Fisher Scientific Inc.
Media Contact Information:
Karen Kirkwood, 781-622-1306
Investor Contact Information:
Ken Apicerno, 781-622-1294